Form D · Biotechnology

MedX Health Corp.

Mississauga, A6 · CIK 0001677483

Offering snapshot reported Jun 21, 2016 · SEC filing

Reported sold: $268K
Investors reported: 10
Minimum accepted: $0
First sale: Jun 6, 2016

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jun 21, 2016	Initial	$267,969	No comparison	10	SEC filing

Offering details

Securities: Equity, Option to acquire, Security to be acquired, Other
Exemptions: 06b
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-265505

The additional $938,873 may be received upon the exercise of share purchase warrants sold inside and outside the U.S. U.S. dollar amounts are based on the Bank of Canada noon rate of exchange reported on June 6, 2016, which was Cdn$1.2856=US$1.00.

Each unit is comprised of one common share and one share purchase warrant. Each warrant is exercisable for one common share at an exercise price of Cdn$0.14 per share for a period of three years.

Source: Form D, filed Jun 21, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
David Breukelman	Director
Louie Canitano	Executive
James Cooke	Executive
Steven T. Guillen	Director
David J. Hennigar	Director
Kenneth Mc Kay	Director
N. Gary Van Nest	Director
Robert Von Der Porten	Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:

1495 Bonhill Road, Unit 1
Mississauga, A6, L5T 1M2